Expression of p53 and bcl-2 in correlation to clinicopathological parameters, hormone receptor status and DNA ploidy in breast cancers

Pathology Research and Practice

Volumn 191, Issue 11, 1995, Pages 1114-1121

  Friedrich, K ^a   Dimmer, V ^a   Haroske, G ^a   Lossnitzer A ^a   Kasper, M ^a   Theissig, F ^a   Kunze, K D ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

bcl 2; Breast cancer; Immunobistochemistry; p53; Prognosis

Indexed keywords

CELL PROTEIN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOLOGY; PLOIDY; PROTEIN EXPRESSION;

EID: 0029611220     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(11)80656-4     Document Type: Article

References (45)

1. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
2. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans
3. Molecular markers in diagnostic pathology. Compendium on the Computerized Cytology and Histology Laboratory
4. The relationship between aneuploidy and p53 over expression during genesis of colorectal adenocarcinoma
5. Immunohistochemical detection of p53 Protein in Mammary carcinoma: An important new independent indicator of prognosis?
6. Histologic grading and prognosis in breast cancer
7. Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow up
8. p53 protein immunostaining in routinely processed paraffin-embedded sections
9. p53 expression in breast cancer
10. Immunhistochemical analysis of p53 and HER-2lneu proteins in human tumors
11. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver
12. Bcl-2 blocks p53 dependent apoptosis
13. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas
14. Relation between p53 overexpression and established prognostic factors in breast cancer
15. The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates with particular reference to oestrogen receptor status
16. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas
17. Der immunhistochemische Nachweis des p53-Proteins in Paraffin eingebetteten Geweben primdrer humaner Mammakarzinome and seine klinische Wertigkeit
18. Down-regulation of bcl-2 by p53 in breast cancer cells
19. Prognostic value of p53 protein expression in breast carcinomas
20. MDM2 gene amplification in metastatic osteosarcoma
21. p53, guardian of ,the genome
22. bcl-2 in normal human breast and carcinoma association with oestrogen receptor-positive epidermal growth factor-negative tumours and in situ cancer
23. The p53 tumour suppressor gene
24. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis
25. p53 associated with cathepsin D in primary breast cancer
26. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escheria coli
27. P53 mutations in human cancer
28. Expression of bcl-2 in the developing human f eatl and infant breast
29. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study
30. Widespread p53 overexpression in human malignant tumors
31. Bcl-2 and the regulation of programmed cell death
32. Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) fur den immun-histochemischen östrogenrezeptor-Nachweis (ER-IRA) im Mammakarzinomgewebe
33. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma
34. p53 as an independent prognostic marker in lymph node-negative breast cancer patients
35. The bcl-2 protein a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
36. Human breast cancer: Frequent p53 allele loss and protein overexpression
37. Bcl-2 Protein in centrocytic lymphoma : A Paraffin section study
38. An immunochemical analysis of the human nuclear phophoprotein p53
39. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells
40. Wild-type p53-triggered apoptosis is inhibeted by bcl-2 in a vmyc-induced T -cell lymphoma line
41. Cell cycle checkpoints genetic instability and cancer
42. P53 in tumour pathology: Can we trust immunocytochemistry?